Genascence

Developer of gene therapies for musculoskeletal and joint diseases

placePalo Alto, California, United States calendar_todayFounded 2017 groups6 employees language genascence.com

Social engagement

Social engagement: 874 social following, 7 posts in the last 12 months — below the industry typical range.

Investor mix

3 investors on record; lead investors include Polymerase Capital, DeepWork Capital, University of Florida.

Investor typeCountShare
Venture capital133%
Other / undisclosed267%

Recent activity

30 Sep 2025
Event
ESGCT25
Coming soon